2016 Glaucoma Market H1 Reseach Review

RnRMarketResearch.com adds “Glaucoma Pipeline Review, H1 2016” Market Research to its database, providing in-depth, high quality, transparent and market-driven, expert’s analysis.

In-detail Table of Contents of Glaucoma Pipeline Market

Companies Involved in Therapeutics Development AC Immune SA, Acadia Pharmaceuticals Inc., Advanced Refractive Technologies, Inc., Aerie Pharmaceuticals, Inc., Allergan Plc, Altacor Limited, Amakem NV, Amarantus Bioscience Holdings, Inc., Astellas Pharma Inc., AUS Bio Limited, Bausch & Lomb Incorporated, BioAxone BioSciences, Inc., Bionure Farma, S.L., Caladrius Biosciences, Inc., Can-Fite BioPharma Ltd., Coronis Partners Ltd., D. Western Therapeutics Institute, Inc., Dompe Farmaceutici S.p.A., F. Hoffmann-La Roche Ltd., Gene Signal International SA, Gilead Sciences, Inc., Glaukos Corporation, GliaCure Inc., Handok Inc., Icon Bioscience, Inc., ID Pharma Co., Ltd., InMed Pharmaceuticals Inc., Inotek Pharmaceuticals Corporation, InSite Vision Incorporated, Isarna Therapeutics GmbH, Kadmon Corporation, LLC, Kala Pharmaceuticals, Inc., Kowa Company, Ltd., Kukje Pharmaceutical Industry Co., Ltd., Lee’s Pharmaceutical Holdings Limited, Lexicon Pharmaceuticals, Inc., Merck & Co., Inc., Merz Pharma GmbH & Co. KgaA, Nemus Bioscience, Inc., Neurotech Pharmaceuticals, Inc., NicOx S.A., NoNO, Inc., Novaliq GmbH, Ocular Therapeutix, Inc., Oculis ehf, Ohr Pharmaceutical Inc., Ono Pharmaceutical Co., Ltd., Otsuka Holdings Co., Ltd., Oxford BioMedica Plc, pSivida Corp., Quark Pharmaceuticals, Inc., Quethera Limited, Regeneron Pharmaceuticals, Inc., Sanofi, Santen Pharmaceutical Co., Ltd., Senju Pharmaceutical Co., Ltd., Shire Plc, SK Biopharmaceuticals Co., Ltd., Sun Pharma Advanced Research Company Ltd., Sylentis S.A.U., UAB Profarma, ViSci Ltd. and vTv Therapeutics LLC

Get discount on this research at http://www.rnrmarketresearch.com/contacts/discount?rname=539814 .

Research provides:

• Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Identify and understand important and diverse types of therapeutics under development for Glaucoma
• Identify potential new clients or partners in the target demographic
• Develop strategic initiatives by understanding the focus areas of leading companies
• Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

The report provides comprehensive information on the therapeutics under development for Glaucoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Glaucoma and features dormant and discontinued projects.

Complete research report at http://www.rnrmarketresearch.com/glaucoma-pipeline-review-h1-2016-market-report.html .

List of figures:

• Number of Products under Development for Glaucoma, H1 2016
• Number of Products under Development for Glaucoma – Comparative Analysis, H1 2016
• Number of Products under Development by Companies, H1 2016
• Number of Products under Investigation by Universities/Institutes, H1 2016
• Comparative Analysis by Late Stage Development, H1 2016
• Comparative Analysis by Clinical Stage Development, H1 2016
• Comparative Analysis by Early Stage Products, H1 2016
• Assessment by Monotherapy Products, H1 2016
• Assessment by Combination Products, H1 2016
• Number of Products by Top 10 Targets, H1 2016
• Number of Products by Stage and Top 10 Targets, H1 2016
• Number of Products by Top 10 Mechanism of Actions, H1 2016
• Number of Products by Stage and Top 10 Mechanism of Actions, H1 2016
• Number of Products by Top 10 Routes of Administration, H1 2016
• Number of Products by Stage and Top 10 Routes of Administration, H1 2016
• Number of Products by Top 10 Molecule Types, H1 2016
• Number of Products by Stage and Top 10 Molecule Types, H1 2016

About Us:

RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.